We are regulated by the MHRA (Medicines & Healthcare Products Regulatory Agency) and in respect of controlled drugs, by the UK Home Office.
Yes, we are able to meet all storage requirements including cold storage and hazardous materials. We have a walk-in cold room for refrigerated storage between 2-8°C. We regularly export temperature sensitive products (including fridge lines, frozen and temperate items) to clients in diverse climates, for example, sub-zero conditions in winter in Northern Europe or extremely high temperatures in the Middle East in summer.
These are generally medicines which are licensed in their country of manufacture (such as the UK), but are not licensed in the importing country. We supply our clients with such medicines, allowing pharmacies and clinicians around the world to supply their patients with the medicines they urgently need.
We are able to offer tailored named-patient programmes, to meet the needs of all of our clients, utilising our infrastructure and knowledge employed throughout our pharmacy wholesale business. Due to our long established relationships with leading pharmaceutical suppliers, we are in a very strong position when it comes to supplying medicines, even highly restricted ones, on a named-patient basis.
Our staff are well aware that with named-patient medicines, the health and wellbeing of an individual is dependent on their ability to supply the correct medicine at the correct time and they take great pride in ensuring that this happens.
We have a robust network of UK based and international suppliers which has been built up over the past four decades. We are able to leverage this network to quickly source medicines and supplies, whether they are out of stock or simply ‘hard to find’.
Currently there is a level of uncertainty with Brexit, so we have introduced a number of processes to ensure there is minimal disruption to our customers. The key thing we have done is to open two European hubs – one in Belgium and the other in The Netherlands. This means we can handle products without them entering the UK, thus reducing the overall time it takes for medicines to get to the end user. It is an extremely important move for us as it gives us greater presence in Europe where a lot of our key clients are based, helping us service customers’ needs more efficiently. It also helps future-proof our business against any forthcoming changes that may occur around Brexit.
We are a truly global company and regularly export to more than 60 different countries. We have longstanding relationships with clients across Europe, Asia, Africa, Australia and the Americas.